Home › Funds › Qube Research & Technologies Ltd › TECH
Qube Research & Technologies Ltd position in TECH
BIO-TECHNE CORP · Health Care
Qube Research & Technologies Ltd reported holding 2,379,411 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$172.4M, representing 0.34% of its reported portfolio and ranking #29 among its reported holdings. Qube Research & Technologies Ltd has disclosed TECH holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Qube Research & Technologies Ltd's TECH position evolved
Qube Research & Technologies Ltd first disclosed a stake in TECH in Q3 2023 at 227,697 shares (US$15.5M). The position peaked in Q3 2026 at 2,379,411 shares, worth US$172.4M. Across 7 filings, Qube Research & Technologies Ltd increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,379,411 shares valued at US$172.4M. Notable position changes include a 97% trim in Q4 2023 (shares fell 9% over the following quarter), a 1238% increase in Q2 2024 (shares rose 12% over the following quarter), a 97% trim in Q3 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 227.70K | $15.50M | New |
| Q4 2023 | 7.10K | $547.84K | Reduce |
| Q1 2024 | 4.30K | $302.68K | Reduce |
| Q2 2024 | 57.54K | $4.12M | Add |
| Q2 2025 | 518.15K | $26.66M | New |
| Q3 2025 | 13.13K | $730.25K | Reduce |
| Q3 2026 | 2.38M | $172.44M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 26 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M sh · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on Qube Research & Technologies Ltd
FAQ
How long has Qube Research & Technologies Ltd held TECH?
Qube Research & Technologies Ltd has disclosed TECH holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Qube Research & Technologies Ltd's current position in TECH?
As of Q3 2026, Qube Research & Technologies Ltd holds 2.38M shares of TECH (BIO-TECHNE CORP), valued at $172.44M, representing 0.34% of its reported portfolio and ranking #29.
Has Qube Research & Technologies Ltd been buying or selling TECH?
In the latest 13F filing (Q3 2026), Qube Research & Technologies Ltd newly opened its position in TECH. The position peaked in Q3 2026 at 2.38M shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.